Platelet–lymphocyte ratio is an independent prognostic factor in patients with ALK -positive non-small-cell lung cancer
Authors:
- 15 August 2016
- journal article
- Published by Taylor & Francis in Future Oncology
- Vol. 13 (1) , 51-61
Abstract
Aim: As the prognostic value of the neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) is unclear in patients with ALK-positive non-small-cell lung cancer (NSCLC), this study assessed the importance of these factors was in this patient subset. Patients & methods: In 173 patients with primary ALK-positive NSCLC at pathological stages I–IV, neutrophil, platelet, lymphocyte, D-dimer and eosinophil levels were recorded before starting treatment. Results: The patients’ median NLR and PLR values were 2.10 and 127.69, respectively. Univariate analyses showed that NLR and PLR values, the D-dimer level and the eosinophil count were all associated with survival. Although multivariate analysis showed PLR to be an independent prognostic factor for overall survival (p = 0.018), NLR was not. Conclusion: PLR is an independent prognostic factor in ALK-positive NSCLC.Keywords
Funding Information
- Pfizer
This publication has 25 references indexed in Scilit:
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-AnalysisJNCI: Journal of the National Cancer Institute, 2014
- Prognostic Significance of Basic Laboratory Methods in Non-Small-Cell-Lung CancerAsian Pacific Journal of Cancer Prevention, 2013
- Immunity, Inflammation, and CancerCell, 2010
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Epidemiology of Lung CancerChest, 2007
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- Survival of Patients with Stage I Lung Cancer Detected on CT ScreeningNew England Journal of Medicine, 2006
- Non-Small Cell Lung Cancer GuidelinesJournal of the National Comprehensive Cancer Network, 2006
- High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostainingBlood, 1996
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994